PP01.25 Incidence and Timing of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor as Monotherapy or in Combination With Chemotherapy
A. Secor, Sophia W. Zhao, L. Wei, P. Das et autres
us (code pays fourni par la source)